DSCSA and Its Impact on the Pharma Supply Chain

Serialization and track & trace requirements of the DSCSA (Drug Supply Chain Security Act) will have a profound impact at all levels of the pharmaceutical supply chain. As Executive VP of Industry Relations, Membership & Education and Chief Operating Officer at the US organization Healthcare Distribution Alliance (HDA), Perry Fri, has a good overview of what is happening on the pharmaceutical supply chain and how DSCSA mandates will impact stakeholders.

In a recent expert interview, he shares his experience and provides insight into how DSCSA will affect the pharma supply chain, gives tips on how to best tackle the challenges and which organization can help.